Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.

By A. Briganti, A. Larcher, F. Abdollah, U. Capitanio, A. Gallina, N. Suardi, M. Bianchi, Maxine Sun, M. Freschi, A. Salonia and 3 more. European Urology, 2012

740 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/2fea1a59e7964748a39485807ae3a5c61912df5f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. A. Heidenreich
2. Michel Bolla
3. N. Mottet
4. J. Bellmunt
5. V. Matveev
6. Steven Joniau
7. F. Zattoni
8. Thomas Wiegel

In Pulmonary and Respiratory Medicine

1. A. Heidenreich
2. Michel Bolla
3. N. Mottet
4. J. Bellmunt
5. V. Matveev
6. Steven Joniau
7. F. Zattoni
8. Thomas Wiegel

Citations in the corpus

• Guidelines on Prostate Cancer (2013, background): “These studies include the Johansson series, which showed that there is a higher risk of dying from PCa in patients surviving more than 15 years with well- and moderately differentiated tumours at diagnosis (31) (LE: 3).”
• EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. (2017, methodology): “The estimated risk for pN+ is 15–40% [49].”
• EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. (2020, background): “The individual risk of finding positive LNs can be estimated using externally validated preoperative nomograms [109].”